Simultaneous densitometric determination of indomethacin and its degradation products, 4-chlorobenzoic acid and 5-methoxy-2-methyl-3-indoleacetic acid, in pharmaceutical preparations

J AOAC Int. 2001 Nov-Dec;84(6):1703-7.

Abstract

A densitometric method was developed for the identification and determination of indomethacin and its degradation products, 4-chlorobenzoic acid and 5-methoxy-2-methyl-3-indoleacetic acid, in pharmaceuticals. To separate these compounds, silica gel-coated thin-layer chromatography plates and the following mobile phase were used: 2-propanol-25% ammonia-water (8 + 1 + 1, v/v). UV densitometric measurements were made by comparing the absorption spectra and Rf values of appropriate standards with the pharmaceutical preparations examined. The conditions for separation were established and a low detection limit was obtained. Average recoveries were 100.69, 90.09, and 91.17% for indomethacin, 4-chlorobeznzoic acid, and 5-methoxy-2-methyl-3-indoleacetic acid, respectively.

Publication types

  • Comparative Study

MeSH terms

  • Anti-Inflammatory Agents, Non-Steroidal / analysis*
  • Chlorobenzoates / analysis
  • Chromatography, Liquid
  • Chromatography, Thin Layer
  • Densitometry / methods*
  • Drug Contamination
  • Humans
  • Indoleacetic Acids / analysis
  • Indomethacin / analysis*
  • Pharmaceutical Preparations / analysis*

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Chlorobenzoates
  • Indoleacetic Acids
  • Pharmaceutical Preparations
  • 5-methoxy-methylindoleacetic acid
  • 4-chlorobenzoic acid
  • Indomethacin